ASSOCIATE
J.D., Ph.D. Chemistry

email: acraig@fdml.com

ANTHONY G. CRAIG joined Fliesler Meyer LLP in 2004. Dr. Craig counsels clients on intellectual property strategies in a number of scientific and technical fields from computer software & networking, medical & electronic devices, industrial manufacturing & process applications, energy devices, imaging, optical devices, telecommunications, chemical, biochemical, biotechnology and pharmaceutical applications.

Education

Anthony Craig was awarded a B.Sc. with honors from La Trobe University, Australia, where he majored in chemistry and applied mathematics. He also holds a Ph.D. in chemistry from the University of New South Wales, Australia, and a J.D. from the University of California Boalt Hall School of Law, Berkeley.

Legal Affiliations

Dr. Craig is a member of the State Bar of California (2005) , is registered to practice before the United States Patent and Trademark Office (2001) and is a member of the American Intellectual Property Law Association and the American Association for the Advancement of Science.

Prior Experience

Prior to joining the firm, Dr. Craig was a postdoctoral researcher at the University of Uppsala in Sweden and subsequently a research scientist at The Salk Institute, La Jolla, California. His research was aimed at understanding the important structural features and mode of action of novel biologically active neuro-peptides, through structure elucidation, synthesis and biological testing.

Dr. Craig has published and lectured extensively on his biomedical research at national and international scientific conferences. He has reviewed articles submitted to peer-reviewed journals including Analytical Chemistry, Organic Mass Spectrometry, Biological Mass Spectrometry, European Journal of Mass Spectrometry and Proceeding of the National Academy of Sciences. Dr. Craig has also reviewed grant requests by independent researchers for The National Institute of Health and The National Science Foundation.

Dr. Craig has significant experience in the biotechnology industry working for small growth orientated companies. He has been a consultant to both small biotechnology and large pharmaceutical companies.

Technical Publications

Dr. Craig is the author of more than ninety peer-reviewed publications in the areas of chemistry, mass spectrometry, biochemistry, peptide/glycopeptide synthesis and biomolecule structure determination.

Selected publications are:

Craig A.G., et al., A novel post translational modification involving bromination of tryptophan: Identification of the residue, L-6-bromotryptophan, in peptides from Conus imperialis and Conus radiatus venom. (1997) J. Biol. Chem. 272: 4689-4698.

England L.J., et al., Inactivation of a serotonin-gated ion channel by a novel polypeptide toxin from marine snails. (1998) Science, 281: 575-578.

Ruffner H., et al., BRCA1 is phosphorylated at serine1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. (1999) Mol. Cell Biology 19 : 4843-4854

Craig A.G., et al., Contulakin-G, An O-Glycosylated Invertebrate Neurotensin. (1999) J. Biol. Chem. 274: 13752-13759.

Kang, J. et al., Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is a-D-Gal-(1-3)- a-D-GalNAc. (2004) Eur. J. Biochem. 271: 1-11.

Patents

Dr. Craig is an inventor on United States patents 5,889,147; 6,344,55; 6,369,193 and 6,489,298.